本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pieris Pharmaceuticals, Inc.

13.60
0.0000
成交量:- -
成交額:74.30萬
市值:1,795.53萬
市盈率:-1.09
高:13.60
開:13.60
低:13.60
收:13.60
52周最高:22.32
52周最低:6.20
股本:132.02萬
流通股本:77.60萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-12.5338
每股收益(LYR):-21.8005
淨資產收益率:-68.21%
總資產收益率:-28.31%
市淨率:1.10
市盈率(LYR):-0.62

資料載入中...

2023/08/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/07/18

重要事件披露

Form 8-K - Current report
2023/07/13

重要事件披露

Form 8-K - Current report
2023/06/27

重要事件披露

Form 8-K - Current report
2023/06/21

重要事件披露

Form 8-K - Current report
2023/06/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/08

重要事件披露

Form 8-K - Current report
2023/05/23

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/19

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/10

重要事件披露

8-K - Current report
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals